Recent Finacing
Recent Raise
Glycemicon AG is a Swiss biotech developing nutraceuticals for prediabetes, diabetes and obesity using an ETH Zurich-derived tetrahydroxylated bile acid that increases smaller adipocytes to improve insulin sensitivity.
Focus Areas
Total Raised
Funding round